Laurus Labs Limited (NSE:LAURUSLABS) — Market Cap & Net Worth

$8.04 Billion USD · Rs743.06 Billion INR · Rank #2657

Market Cap & Net Worth: Laurus Labs Limited (LAURUSLABS)

Laurus Labs Limited (NSE:LAURUSLABS) has a market capitalization of $8.04 Billion (Rs743.06 Billion) as of June 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #2657 globally and #108 in its home market, demonstrating a -2.01% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laurus Labs Limited's stock price Rs1376.40 by its total outstanding shares 539856582 (539.86 Million). Review LAURUSLABS current and long-term liabilities to assess the company's total debt and financial obligations.

Laurus Labs Limited Market Cap History: 2016 to 2026

Laurus Labs Limited's market capitalization history from 2016 to 2026. Data shows growth from $526.17 Million to $8.04 Billion (33.27% CAGR).

Index Memberships

Laurus Labs Limited is a constituent of 8 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY PHARMA CNXPHARMA	$91.62 Billion	8.77%	#6 of 20
NIFTY SMALLCAP 100 NIFSMCP100	$196.29 Billion	4.09%	#1 of 100
NIFTY 500 NIFTY500	$3.11 Trillion	0.26%	#100 of 500
NIFTY HEALTHCARE NIFTYHEALTHCARE	$110.04 Billion	7.30%	#8 of 20
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.14 Trillion	0.71%	#34 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.25%	#100 of 750
NIFTY SMALLCAP 250 NISM250	$385.45 Billion	2.08%	#1 of 250
NIFTY SMALLCAP 50 NISM50	$116.89 Billion	6.87%	#1 of 50

Weight: Laurus Labs Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Laurus Labs Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Laurus Labs Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.12x

Laurus Labs Limited's market cap is 0.12 times its annual revenue

Industry average: 0.53x Lower than industry average

Latest Price to Earnings (P/E) Ratio

1.81x

Laurus Labs Limited's market cap is 1.81 times its annual earnings

Industry average: 0.02x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$526.17 Million	$17.78 Billion	$1.34 Billion	0.03x	0.39x
2017	$595.49 Million	$19.05 Billion	$1.90 Billion	0.03x	0.31x
2018	$417.69 Million	$20.56 Billion	$1.68 Billion	0.02x	0.25x
2019	$406.26 Million	$22.92 Billion	$937.64 Million	0.02x	0.43x
2020	$2.03 Billion	$28.32 Billion	$2.55 Billion	0.07x	0.80x
2021	$3.11 Billion	$48.14 Billion	$9.84 Billion	0.06x	0.32x
2022	$2.18 Billion	$49.36 Billion	$8.28 Billion	0.04x	0.26x
2023	$2.51 Billion	$60.41 Billion	$7.90 Billion	0.04x	0.32x
2024	$3.52 Billion	$50.41 Billion	$1.61 Billion	0.07x	2.19x
2025	$6.47 Billion	$55.54 Billion	$3.58 Billion	0.12x	1.81x

Competitor Companies of LAURUSLABS by Market Capitalization

Companies near Laurus Labs Limited in the global market cap rankings as of June 18, 2026.

Key companies related to Laurus Labs Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#513	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#561	GALDERMA GROUP AG	NYSE:GALDY	$48.78 Billion	$43.22
#624	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$44.20 Billion	CN¥47.35
#635	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€13.60

Laurus Labs Limited Historical Marketcap From 2016 to 2026

Between 2016 and today, Laurus Labs Limited's market cap moved from $526.17 Million to $ 8.04 Billion, with a yearly change of 33.27%.

Year	Market Cap	Change (%)
2026	Rs8.04 Billion	+24.22%
2025	Rs6.47 Billion	+83.84%
2024	Rs3.52 Billion	+40.34%
2023	Rs2.51 Billion	+15.19%
2022	Rs2.18 Billion	-30.10%
2021	Rs3.11 Billion	+53.28%
2020	Rs2.03 Billion	+400.06%
2019	Rs406.26 Million	-2.74%
2018	Rs417.69 Million	-29.86%
2017	Rs595.49 Million	+13.18%
2016	Rs526.17 Million	--

End of Day Market Cap According to Different Sources

On Jun 17th, 2026 the market cap of Laurus Labs Limited was reported to be:

Source	Market Cap
Yahoo Finance	$8.04 Billion USD
MoneyControl	$8.04 Billion USD
MarketWatch	$8.04 Billion USD
marketcap.company	$8.04 Billion USD
Reuters	$8.04 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Laurus Labs Limited

NSE:LAURUSLABS India Drug Manufacturers - Specialty & Generic

Market Cap

$8.04 Billion

Rs743.06 Billion INR

Market Cap Rank

#2657 Global

#108 in India

Share Price

Rs1376.40

Change (1 day)

-0.91%

52-Week Range

Rs646.25 - Rs1446.80

All Time High

Rs1446.80